Market Overview The global angiogenesis inhibitors and stimulators market was valued at USD 27.61 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 9.3% during the forecast period. The market is poised for significant growth driven by rising prevalence of cancer, increasing investments in oncology research, and the advancement of targeted therapies....